Home > Healthcare > Analytical Instruments > Immunoassay > ELISA Analyzers Market
ELISA Analyzers Market size was valued at around USD 587.1 million in 2023 and is estimated to grow at 4.2% CAGR from 2024 to 2032. ELISA analyzer is a sophisticated laboratory instrument used to automate and streamline the process of conducting enzyme-linked immunosorbent assays (ELISA). It is a common technique in immunology used to detect the presence of specific antibodies or antigens in a sample.
Chronic diseases such as cancer, cardiovascular diseases, and autoimmune disorders, along with infectious diseases like HIV/AIDS, hepatitis, and COVID-19, are on the rise globally. For instance, the World Health Organization (WHO) forecasts a significant surge in new cancer cases by 2050, with projections indicating over 35 million new cases. This represents a substantial 77% increase compared to the estimated 20 million cases recorded in 2022. This escalating disease burden necessitates efficient and accurate diagnostic methods to detect and monitor these conditions. ELISA analyzers play a crucial role in diagnosing and monitoring such diseases by detecting specific antibodies or antigens in patient samples.
Furthermore, technological advancements in diagnostic testing have greatly enhanced the accuracy and sensitivity of ELISA assays. These improvements enable healthcare professionals to detect diseases at an early stage, facilitating timely intervention and improving patient outcomes. ELISA analyzers offer precise and reliable results, making them indispensable tools in clinical laboratories and healthcare settings.
Report Attribute | Details |
---|---|
Base Year: | 2023 |
ELISA Analyzers Market Size in 2023: | USD 587.1 Million |
Forecast Period: | 2024 – 2032 |
Forecast Period 2024 – 2032 CAGR: | 4.2% |
2024 – 2032 Value Projection: | USD 844.3 Million |
Historical Data for: | 2021 – 2023 |
No. of Pages: | 198 |
Tables, Charts & Figures: | 341 |
Segments covered: | Type, Mode, Modality, Application, End-use, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|